TY - JOUR
AU - Bremner, Luca
AU - Cohen, Yosef
AU - Karthikeyan, Ganesan
AU - Lu, Bin
AU - Albadr, Amjed
AU - Bom, Hee-Seung Henry
AU - Dautov, Tairkhan
AU - Fatima, Shazia
AU - Haidar, Mohamad
AU - Iguchi, Nobuo
AU - Khiewvan, Benjapa
AU - Nanayakkara, Damayanthi
AU - Patel, Chetan
AU - Rozikhodjaeva, Gulnora
AU - Better, Nathan
AU - Dorbala, Sharmila
AU - Malkovskiy, Eli
AU - Randazzo, Michael
AU - Gianmarile, Francesco
AU - Pynda, Yaroslav
AU - Dondi, Maurizio
AU - Paez, Diana
AU - Dai, Kathy Z.
AU - Pascual, Thomas N.B.
AU - Kang, Felix Y.J.
AU - Nguyen, Phuoc Minh Hiep
AU - Cerci, Rodrigo
AU - Shaw, Leslee J.
AU - Villines, Todd C.
AU - Vitola, Joao
AU - Williams, Michelle C.
AU - Choi, Andrew D.
AU - Einstein, Andrew J.
PY - 2025
DA - February
TI - Recovery of cardiovascular testing in Asia during the COVID-19 pandemic: findings from the INCAPS COVID 2 study
JO - Open Heart
VL - 12
DO - https://doi.org/10.1136/openhrt-2024-002935
AB - Background Understanding pandemic-related reductions and subsequent recovery of cardiovascular testing in Asia is important for guiding regional public health efforts. Objectives This study sought to evaluate the recovery of cardiovascular testing in Asia 1 year into the COVID-19 pandemic. Methods In this subanalysis of a worldwide survey on the impact of COVID-19 on cardiovascular diagnostic care in April 2020 and April 2021, recovery of testing volume in Asia was compared among subregions, World Bank income groups and imaging modalities. Results Of 669 sites worldwide, 164 sites were in 33 Asian countries. Cardiovascular testing volumes in Asia decreased by 53% from March 2019 to April 2020, then recovered 96% of this decrease by April 2021, compared with 98% recovery in the rest of the world. Eastern Asia and Western and Central Asia reported recovery rates of 123% and 110%, compared with 50% and 80% recovery in Southern and South-eastern Asia. Testing volumes among high-income and upper-middle-income Asian countries recovered to 117% and 121% but remained depressed at 49% and 14% recovery in lower-middle and low-income countries, respectively. Stress ECG, stress echo and stress positron emission tomography studies experienced median reductions of 48%, 35% and 57% in testing volume between March 2019 and April 2021, while volumes of coronary artery calcium, coronary CT angiography and cardiac MR remained stable during this period. Conclusions The recovery of cardiovascular testing in Asia 1 year into the COVID-19 pandemic lagged in the Southern and South-eastern subregions, as well as in lower-income countries. Recovery favoured advanced cardiac imaging modalities over standard stress testing modalities.
PB - BMJ Publishing Group
UR - https://www.research.ed.ac.uk/en/publications/51a949c5-b026-47b7-8747-232eb8a906b1
KW - Coronavirus (COVID-19)
ER